Healthcare News

Allowed claims cover Lowe syndrome and Dent disease 2; Can-Fite holds development, commercialization, and out-licensing rights for these indications under its agreement with Fondazione Telethon Ramat...

– Afimetoran, an investigational oral, once-daily, equipotent TLR7/8 inhibitor, targets a central driver of lupus biology with the potential to address both cutaneous and systemic disease – – Global,...

BEDFORD, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today...

NASHVILLE, Tenn., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced the launch of HarrowRx, a...

Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost Savings Higher Cultivation...

Lexeo Therapeutics to Present Multiple Oral and Poster Presentations at Key Scientific Conferences in November

ET-900 targets a potential new indication for mecasermin, the active ingredient in Eton’s INCRELEX®Eton has licensed patent rights from Baylor College of Medicine covering the use of insulin-like...

BETHLEHEM, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc., a global leader in point-of-care and home diagnostic tests and sample management solutions, announced today that it has...

بيت لحم، بنسلفانيا, Nov. 02, 2026 (GLOBE NEWSWIRE) --  أعلنتOraSure Technologies, Inc.، الشركة العالمية الرائدة في مجال اختبارات التشخيص في نقاط الرعاية الصحية والمنازل وحلول إدارة العينات، اليوم...

BETHLEHEM, Pennsylvanie, 02 nov. 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc., leader mondial des tests diagnostiques réalisables sur le lieu de soins ou à domicile et des solutions de...